Nordanskog Pia, Hultén Martin, Landén Mikael, Lundberg Johan, von Knorring Lars, Nordenskjöld Axel
From the *Department of Medical and Health Sciences, Linköping University, Linköping; †Psychiatric Neuromodulation Unit (PNU), Dept of Clinical Sciences Lund, Faculty of Medicine, Lund University, Lund; ‡Institute of Neuroscience and Physiology, The Sahlgrenska Academy at Gothenburg University, Gothenburg; §Department of Clinical Neuroscience, Karolinska Institutet and Section for Affective Disorders, Northern Stockholm Psychiatry, Stockholm; ∥Department of Neuroscience, Psychiatry, Uppsala university, Uppsala; and ¶Department of Psychiatry, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
J ECT. 2015 Dec;31(4):263-7. doi: 10.1097/YCT.0000000000000243.
The use of electroconvulsive therapy (ECT) varies across countries. The aim of this study was to describe and explore the use of ECT in Sweden in 2013.
The Swedish mandatory patient register of the National Board of Health and Welfare includes information on diagnoses and treatments, including ECT. All 56 hospitals that provide ECT in Sweden also report to the nonmandatory national quality register for ECT, which contains information on patient and treatment characteristics. In this study, we combined data from both registers. In addition, all hospitals responded to a survey concerning equipment and organization of ECT.
We identified 3972 unique patients who received ECT in Sweden in 2013. This translates into 41 ECT-treated individuals per 100,000 inhabitants. Of these patients, 85% opted to participate in the quality register. The median age was 55 years (range, 15-94 years), and 63% were women. The indication was depression in 78% of the treatment series. Of 4 711 hospitalized patients with severe depression, 38% received ECT. The median number of treatments per index series was 7. Unilateral treatment was used in 86% of the series.
In Sweden, ECT is used at a relatively high rate as compared with other western countries, and the rate was unchanged from the last survey in 1975. However, there is room for improvement in the specificity of use and availability of ECT for disorders where ECT is considered a first-line treatment.
电休克治疗(ECT)在各国的使用情况有所不同。本研究旨在描述和探讨2013年瑞典ECT的使用情况。
瑞典国家卫生和福利委员会的强制性患者登记册包含诊断和治疗信息,包括ECT。瑞典所有提供ECT的56家医院也会向非强制性的国家ECT质量登记册报告,该登记册包含患者和治疗特征信息。在本研究中,我们合并了两个登记册的数据。此外,所有医院都回复了一份关于ECT设备和组织的调查问卷。
我们确定了2013年在瑞典接受ECT治疗的3972名独特患者。这相当于每10万居民中有41名接受ECT治疗的个体。在这些患者中,85%选择参与质量登记册。患者的中位年龄为55岁(范围为15 - 94岁),63%为女性。78%的治疗系列的适应症为抑郁症。在4711名住院的重度抑郁症患者中,38%接受了ECT治疗。每个索引系列的治疗中位数为7次。86%的系列采用单侧治疗。
与其他西方国家相比,瑞典ECT的使用率相对较高,且自1975年的上次调查以来该比率没有变化。然而,在ECT被视为一线治疗的疾病的使用特异性和可及性方面仍有改进空间。